rxstat › Shortages › Esomeprazole Naproxen
Esomeprazole Naproxen shortage status
Widespread shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Esomeprazole Naproxen is in a widespread shortage in Canada. 2 of 3 reported products are affected. The latest manufacturer estimate for full recovery is Nov 24, 2026.
In shortage since
Mar 4, 2026
Est. full return
Nov 24, 2026
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.
Reports by product
Active shortageMYLAN-NAPROXEN/ESOMEPRAZOLE MR
20MG
500MG · TABLET (IMMEDIATE AND DELAYED-RELEASE) · MYLAN PHARMACEUTICALS ULC
DIN 02443449 · since Mar 4, 2026, est. end Nov 24, 2026 · Disruption of the manufacture of the drug.
Active shortageMYLAN-NAPROXEN/ESOMEPRAZOLE MR
20MG
375MG · TABLET (IMMEDIATE AND DELAYED-RELEASE) · MYLAN PHARMACEUTICALS ULC
DIN 02458608 · since Mar 13, 2026, est. end Nov 24, 2026 · Disruption of the manufacture of the drug.
ResolvedMYLAN-NAPROXEN/ESOMEPRAZOLE MR
20MG
500MG · TABLET (IMMEDIATE AND DELAYED-RELEASE) · MYLAN PHARMACEUTICALS ULC
DIN 02443449 · ended Aug 18, 2025 · Disruption of the manufacture of the drug.
ResolvedMYLAN-NAPROXEN/ESOMEPRAZOLE MR
20MG
500MG · TABLET (IMMEDIATE AND DELAYED-RELEASE) · MYLAN PHARMACEUTICALS ULC
DIN 02443449 · ended Jul 23, 2025 · Disruption of the manufacture of the drug.
ResolvedMYLAN-NAPROXEN/ESOMEPRAZOLE MR
20MG
500MG · TABLET (IMMEDIATE AND DELAYED-RELEASE) · MYLAN PHARMACEUTICALS ULC
DIN 02443449 · ended Jul 8, 2025 · Disruption of the manufacture of the drug.
ResolvedMYLAN-NAPROXEN/ESOMEPRAZOLE MR
20MG
500MG · TABLET (IMMEDIATE AND DELAYED-RELEASE) · MYLAN PHARMACEUTICALS ULC
DIN 02443449 · ended Apr 21, 2025 · Disruption of the manufacture of the drug.
ResolvedMYLAN-NAPROXEN/ESOMEPRAZOLE MR
20MG
500MG · TABLET (IMMEDIATE AND DELAYED-RELEASE) · MYLAN PHARMACEUTICALS ULC
DIN 02443449 · ended Apr 11, 2025 · Disruption of the manufacture of the drug.
ResolvedMYLAN-NAPROXEN/ESOMEPRAZOLE MR
20MG
375MG · TABLET (IMMEDIATE AND DELAYED-RELEASE) · MYLAN PHARMACEUTICALS ULC
DIN 02458608 · ended Mar 13, 2025 · Disruption of the manufacture of the drug.
ResolvedMYLAN-NAPROXEN/ESOMEPRAZOLE MR
20MG
500MG · TABLET (IMMEDIATE AND DELAYED-RELEASE) · MYLAN PHARMACEUTICALS ULC
DIN 02443449 · ended Feb 10, 2025 · Disruption of the manufacture of the drug.
ResolvedMYLAN-NAPROXEN/ESOMEPRAZOLE MR
20MG
500MG · TABLET (IMMEDIATE AND DELAYED-RELEASE) · MYLAN PHARMACEUTICALS ULC
DIN 02443449 · ended Dec 19, 2024 · Disruption of the manufacture of the drug.
ResolvedMYLAN-NAPROXEN/ESOMEPRAZOLE MR
20MG
500MG · TABLET (IMMEDIATE AND DELAYED-RELEASE) · MYLAN PHARMACEUTICALS ULC
DIN 02443449 · ended Feb 1, 2024 · Disruption of the manufacture of the drug.
ResolvedMYLAN-NAPROXEN/ESOMEPRAZOLE MR
20MG
375MG · TABLET (IMMEDIATE AND DELAYED-RELEASE) · MYLAN PHARMACEUTICALS ULC
DIN 02458608 · ended Jan 11, 2024 · Disruption of the manufacture of the drug.
Showing 12 of 33 reports. All reports are on file with Health Canada.
What's happening
Esomeprazole Naproxen is currently affected by 2 active shortage reports filed with Health Canada by MYLAN PHARMACEUTICALS ULC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Esomeprazole Naproxen is classified under “ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS” (ATC M01AE).
Recent changes
Common questions
When will Esomeprazole Naproxen be back in stock in Canada?
The latest manufacturer estimate is Nov 24, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Esomeprazole Naproxen in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
All antiinflammatory/antirheumatic prod.,non-steroids shortage statuses →
Guides: what to do when your medication is in shortage · how to read shortage reports
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.